WILSON JAMES N sold 0.9% of their position (10K shares) of CORCEPT THERAPEUTICS INC on the open market
Open‑market sale worth $883.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 7/17/2026ACC: 0001193125-26-308061
-10K
Net shares
Net seller
$883.0K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
10K disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−1.08K
Price / share
$86.78
Trade value
$93.63K
% of position
0.1%
7/15/2026
1.09M→1.09M
Common Stock
Indirect
Shares
−3.97K
Price / share
$87.74
Trade value
$348.22K
% of position
0.4%
7/15/2026
1.09M→1.09M
Common Stock
Indirect
Shares
−2.97K
Price / share
$88.81
Trade value
$264.12K
% of position
0.3%
7/15/2026
1.09M→1.09M
Common Stock
Indirect
Shares
−1.98K
Price / share
$89.49
Trade value
$177.01K
% of position
0.2%
7/15/2026
1.09M→1.08M
Total
Net shares
−10K
Net value
-$882.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/15/2026 | S · Sale | −1.08K | $86.78 | $93.63K | 0.1% | 1.09M | 1.09M |
| Common Stock Indirect | 7/15/2026 | S · Sale | −3.97K | $87.74 | $348.22K | 0.4% | 1.09M | 1.09M |
| Common Stock Indirect | 7/15/2026 | S · Sale | −2.97K | $88.81 | $264.12K | 0.3% | 1.09M | 1.09M |
| Common Stock Indirect | 7/15/2026 | S · Sale | −1.98K | $89.49 | $177.01K | 0.2% | 1.09M | 1.08M |
| Total | −10K | -$882.99K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned200K
Common Stock
IndirectShares owned200K
Total
400K indirect400K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 200K | Indirect |
| Common Stock | 200K | Indirect |
| Total | 400K | 400K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported